- In a recent study from Israel, a connection was found between Covid-19 infection and a
higher likelihood of being diagnosed with Guillain-Barre syndrome (GBS) within six
weeks. - Guillain-Barre syndrome is a rare autoimmune disorder where the body’s immune
system mistakenly attacks the peripheral nerves. - It Is more common in adults and males, but it can affect people of all ages.
- The first symptoms of this syndrome include weakness or tingling sensations.
- They usually start in the legs, and can spread to the arms and face.
- For some people, these symptoms can lead to paralysis of the legs, arms, or muscles in
the face. - It is often preceded by an infection.
- This could be a bacterial or viral infection.
- The most frequently associated infections include Campylobacter jejuni, Epstein-Barr
virus (EBV), cytomegalovirus (CMV), and the bacteria responsible for pneumonia and
urinary tract infections. - It may also be triggered by vaccine administration or surgery.
- There is no known cure for this syndrome.
- The most commonly used treatment is intravenous immunoglobulin (IVIG), which is
made from donated blood that contains healthy antibodies.
